Literature DB >> 27325327

The Impact of Patient-Centered versus Didactic Education Programs in Chronic Patients by Severity: The Case of Type 2 Diabetes Mellitus.

Paul Windrum1, Manuel García-Goñi2, Holly Coad3.   

Abstract

BACKGROUND: Education leads to better health-related decisions and protective behaviors, being especially important for patients with chronic conditions. Self-management education programs have been shown to be beneficial for patients with different chronic conditions and to have a higher impact on health outcomes than does didactic education.
OBJECTIVE: To investigate improvements in glycemic control (measured by glycated hemoglobin A1c) in patients with type 2 diabetes mellitus.
METHODS: Our comparative trial involved one group of patients receiving patient-centered education and another receiving didactic education. We dealt with selection bias issues, estimated the different impact of both programs, and validated our analysis using quantile regression techniques.
RESULTS: We found evidence of better mean glycemic control in patients receiving the patient-centered program, which engaged better patients. Nevertheless, that differential impact is nonmonotonic. Patients initially at the healthy range at the patient-centered program maintained their condition better. Patients close to, but not within, the healthy range benefited equally from attending either program. Patients with very high glycemic level benefited significantly more from attending the patient-centered program. Finally, patients with the worst initial glycemic control (far from the healthy range) improved equally their diabetic condition, regardless of which program they attended.
CONCLUSIONS: Different patients are sensitive to different categories of education programs. The optimal, cost-effective design of preventative programs for patients with chronic conditions needs to account for the different impact in different "patient categories." This implies stratifying patients and providing the appropriate preventative education program, or looking for alternative policy implementations for unresponsive patients who have the most severe condition and are the most costly.
Copyright © 2016 International Society for Pharmacoeconomics and Outcomes Research (ISPOR). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  chronic disease self-management; patient-centered education; quantile regression

Mesh:

Substances:

Year:  2016        PMID: 27325327     DOI: 10.1016/j.jval.2016.01.014

Source DB:  PubMed          Journal:  Value Health        ISSN: 1098-3015            Impact factor:   5.725


  4 in total

1.  A systematic review of impact of person-centred interventions for serious physical illness in terms of outcomes and costs.

Authors:  Kennedy Bashan Nkhoma; Amelia Cook; Alessandra Giusti; Lindsay Farrant; Ruwayda Petrus; I Petersen; Liz Gwyther; Sridhar Venkatapuram; Richard Harding
Journal:  BMJ Open       Date:  2022-07-13       Impact factor: 3.006

2.  Specializing Nurses as An Indirect Education Program for Stoma Patients.

Authors:  Manuel García-Goñi
Journal:  Int J Environ Res Public Health       Date:  2019-06-27       Impact factor: 3.390

3.  Protocol of a clinical trial study involving educational intervention in patients treated with warfarin.

Authors:  Josiane Moreira da Costa; Milena Soriano Marcolino; Heloisa Carvalho Torres; Raissa Eda de Resende; Renan Pedra de Souza; Hannah Cardoso Barbosa; Daniel Dias Ribeiro; Maria Auxiliadora Parreiras Martins
Journal:  Medicine (Baltimore)       Date:  2019-05       Impact factor: 1.817

4.  Using electronic health records to quantify and stratify the severity of type 2 diabetes in primary care in England: rationale and cohort study design.

Authors:  Salwa S Zghebi; Martin K Rutter; Darren M Ashcroft; Chris Salisbury; Christian Mallen; Carolyn A Chew-Graham; David Reeves; Harm van Marwijk; Nadeem Qureshi; Stephen Weng; Niels Peek; Claire Planner; Magdalena Nowakowska; Mamas Mamas; Evangelos Kontopantelis
Journal:  BMJ Open       Date:  2018-06-30       Impact factor: 2.692

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.